These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10089836)

  • 1. Energy levels for defibrillation: what is of real clinical importance?
    Fotuhi PC; Epstein AE; Ideker RE
    Am J Cardiol; 1999 Mar; 83(5B):24D-33D. PubMed ID: 10089836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracardiac atrial defibrillation.
    Dosdall DJ; Ideker RE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S51-6. PubMed ID: 17336885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between shock energy and postdefibrillation ventricular arrhythmias in patients with implantable defibrillators.
    Zivin A; Souza J; Pelosi F; Flemming M; Knight BP; Goyal R; Morady F; Strickberger SA
    J Cardiovasc Electrophysiol; 1999 Mar; 10(3):370-7. PubMed ID: 10210500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shock timing lowers transvenous defibrillation energy requirement.
    Hsu W; Lin Y; Lang DJ; Jones JL
    J Electrocardiol; 1998; 31 Suppl():35-40. PubMed ID: 9988003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
    J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in implantable cardioverter-defibrillator therapy.
    Raitt MH; Bardy GH
    Curr Opin Cardiol; 1994 Jan; 9(1):23-9. PubMed ID: 8199367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter Low-Energy Endotak Trial.
    Neuzner J; Liebrich A; Jung J; Himmrich E; Pitschner HF; Winter J; Vester EG; Michel U; Nisam S; Heisel A
    Am J Cardiol; 1999 Mar; 83(5B):34D-39D. PubMed ID: 10089837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of the effect of biphasic waveform defibrillation on ventricular pacing thresholds.
    Kudenchuk PJ; Poole JE; Dolack GL; Gleva MJ; Anderson J; Troutman C; Bardy GH
    J Cardiovasc Electrophysiol; 1997 May; 8(5):485-95. PubMed ID: 9160224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
    Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L
    Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of different tilts with biphasic defibrillation in humans.
    Natale A; Sra J; Krum D; Dhala A; Deshpande S; Jazayeri M; Newby K; Wase A; Axtell K; VanHout WL; Akhtar M
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):197-206. PubMed ID: 8834689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of shock timing on defibrillation success.
    Hsu W; Lin Y; Heil JE; Jones J; Lang DJ
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):153-7. PubMed ID: 9121980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The implantable automatic cardioverter-defibrillator].
    Klein H; Tröster J; Trappe HJ; Becht I; Siclari F
    Herz; 1990 Apr; 15(2):111-25. PubMed ID: 2188891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of failed defibrillation shocks on electrogram amplitude in a nonintegrated transvenous defibrillation lead system.
    Brady PA; Friedman PA; Stanton MS
    Am J Cardiol; 1995 Sep; 76(8):580-4. PubMed ID: 7677081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do some patients have high defibrillation thresholds at defibrillator implantation? Answers from basic research.
    Hillsley RE; Wharton JM; Cates AW; Wolf PD; Ideker RE
    Pacing Clin Electrophysiol; 1994 Feb; 17(2):222-39. PubMed ID: 7513408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transvenous biventricular defibrillation.
    Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
    Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety margins: lessons from the Low Energy Endotak Trial (LEET).
    Neuzner J
    Am J Cardiol; 1996 Sep; 78(5A):26-32. PubMed ID: 8820833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.